Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-7-4
pubmed:abstractText
In the present study, we investigated the chronological alterations in SOD1 and its copper chaperone (chaperone for superoxide dismutase, CCS) immunoreactivities and their neuroprotective effects against neuronal damage in the gerbil hippocampus after 5 min of transient forebrain ischemia. SOD1 and CCS immunoreactivities were significantly increased in the stratum pyramidale of the CA1 region at 24 and 12 h after ischemic insult, respectively. At 24 h after ischemic insult, the SOD1 and CCS immunoreactivities were colocalized in the CA1 pyramidal cells of the stratum pyramidale. Thereafter, their immunoreactivities were significantly decreased in the CA1 region. To elucidate the effects of CCS or CCS/SOD1, we constructed the expression vectors PEP-1-SOD and PEP-1-CCS. In the CCS-treated group and the CCS/SOD1-treated group, 43.9 and 78.9% pyramidal cells, respectively, compared to the sham-operated group, were stained with cresyl violet 5 or 7 days after ischemic insult. The distribution pattern of active astrocytes and microglia in the PEP-CCS/SOD1-treated group 5 days after ischemic insult was similar to that of the sham-operated group. In addition, the SOD activity in the PEP-CCS- or PEP-CCS/SOD1-treated group was maintained by 10 days after ischemic insult. The SOD activity was higher in the PEP-CCS/SOD1-treated group vs the CCS-treated group. These results suggest that the enhanced expression of SOD1 and CCS may be related to compensatory mechanisms against ischemic damage and that cotreatment with CCS and SOD1 has a greater neuroprotective effect than treatment with CCS or SOD1 in isolation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-10051199, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-10221913, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-10375685, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-10561523, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-10582606, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-10629753, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-10751433, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-10816601, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-10944535, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-11027223, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-11500508, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-11524666, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-11731788, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-11756504, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-11858695, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-12832419, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-12885586, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-1326527, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-1332049, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-1402908, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-15477017, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-15761197, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-16404156, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-17129739, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-17697934, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-4578091, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-5389100, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-7687996, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-7862672, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-8446170, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-9346482, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-9658063, http://linkedlifedata.com/resource/pubmed/commentcorrection/15993338-9926619
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0891-5849
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
392-402
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Copper chaperone for Cu,Zn-SOD supplement potentiates the Cu,Zn-SOD function of neuroprotective effects against ischemic neuronal damage in the gerbil hippocampus.
pubmed:affiliation
Department of Anatomy, College of Medicine, Hallym University, Chunchon 200-702, South Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't